HemoSonics Wins Best Medical Device Company in Triangle Business Journal’s 2025 Life Sciences Awards

DURHAM, N.C.--(BUSINESS WIRE)--May 27, 2025--

HemoSonics, LLC, a medical device company focused on acute bleeding management, today announced the company has won the Triangle Business Journal 2025 Life Sciences Award in the Best Medical Device Company category for its Quantra Hemostasis System’s groundbreaking work in viscoelastic testing. HemoSonics’ Quantra Hemostasis System speeds up decision-making in the operating room, improves patient outcomes and reduces healthcare costs by providing optimized coagulation information.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527660439/en/

According to data from the North Carolina Biotechnology Center, North Carolina is home to 840 life sciences companies, with the lion’s share based in the Triangle. The Triangle Business Journal’s Life Sciences Awards recognize 12 individuals and research organizations from the Research Triangle, North Carolina (Raleigh, Durham and Chapel Hill region) that are leading and breaking ground in this field. The broad spectrum of the life sciences arena encompasses biotechnology, pharmaceuticals, clinical research, human health, medical devices and diagnostics, and other related fields.

The HemoSonics Quantra Hemostasis System consists of the Quantra Hemostasis Analyzer, along with QPlus and QStat Cartridges. The System provides fast, comprehensive whole-blood coagulation analysis at the point of care or in laboratory settings in under 15 minutes, empowering clinicians with information to inform patient-centered decisions that improve care and optimize blood product usage. The Quantra System uses innovative SEER Sonorheometry (Sonic Estimation of Elasticity via Resonance), a proprietary medical-grade ultrasound technology that measures the coagulation properties of a whole blood sample.

HemoSonics’ Quantra System is FDA-cleared for cardiovascular surgery, trauma, liver transplantation, and major orthopedic surgery. It requires minimal resources to maintain, is easy to operate and interpret, and enables hospitals to standardize a clinically and operationally efficient viscoelastic testing program.

“The Research Triangle Park has long been recognized as a catalyst for pioneering technologies in biotechnology, medical devices, and health technology, and this community is one of the key reasons we chose Durham for our headquarters,” said Bob Roda, HemoSonics President and CEO. “Innovation is at the heart of what we do at HemoSonics, and we’re thrilled to be mentioned alongside companies who are changing the world for the better through medical and scientific advances.”

HemoSonics’ Quantra Hemostasis System technology has received numerous accolades, including the 2024 TIME Best Inventions, 2024 Fast Company Most Innovative Companies (Medtech ), 2024 Edison Awards (Point-of-Care and Therapeutic Solutions), and the 2024 Deloitte Fast 500, which recognizes the fastest-growing companies in North America.

About HemoSonics:

HemoSonics, LLC is a medical device technology company focused on acute bleeding management, resulting in better patient care and lower overall medical costs. The Quantra Hemostasis Analyzer, HemoSonics' flagship product, is designed to improve patient outcomes and reduce healthcare costs by providing optimized coagulation information. The Quantra System's easy and fast interpretation enables simple, more efficient point-of-care and laboratory bleeding management.

Based in Durham, North Carolina, HemoSonics is part of the Stago Group, a leading in vitro diagnostics company dedicated to exploring thrombosis and hemostasis. Visit HemoSonics.com to learn more.

HemoSonics' Quantra Hemostasis System with QStat Cartridge provides comprehensive blood analysis detailing hemostasis in the operating room in less than 15 minutes, and is FDA-cleared for use in cardiovascular surgery, trauma, liver transplantation, and major orthopedic surgery. The Quantra Hemostasis System technology has received numerous accolades, including the Triangle Business Journal's 2025 Life Sciences Award in the Best Medical Device Company category, 2024 TIME Best Inventions, 2024 Fast Company Most Innovative Companies (Medtech), 2024 Edison Awards (Point-of-Care and Therapeutic Solutions), and the 2024 Deloitte Fast 500, which recognizes the fastest-growing companies in North America.

LANSING, Mich. (AP) — Michigan Lt. Gov. Garlin Gilchrist II announced Monday he is suspending his campaign for governor and instead joining the race for secretary of state of the battleground state.

Gilchrist, a progressive Democrat from Detroit, did not cite a specific reason for the change in his video announcement, but said he is not finished being a “public servant.” His departure clears up the Democratic primary and benefits the frontrunner, Jocelyn Benson, who is the current Secretary of State, in the race to replace term-limited Gov. Gretchen Whitmer.

The secretary of state is Michigan's top election official, a highly politicized and visible role since the 2020 presidential election.

“Michigan has been ground zero in the battle for free and fair elections before, and it will be again,” Gilchrist said.

As Whitmer’s second in command and her running mate in two elections, Gilchrist struggled to match Benson’s name recognition and fundraising. He reported having around $378,000 of cash on hand as of October compared to Benson’s $2.98 million.

Benson is now set to face only Genesee County Sheriff Chris Swanson in the Democratic primary in August.

The inclusion of a well-known independent candidate has created a new problem for Democrats this year. Former Detroit Mayor Mike Duggan is avoiding costly primaries altogether by running as an independent. The Michigan Democratic Party slammed the former Democrat last week for not standing up to President Donald Trump’s second term policies.

In the Republican primary, U.S. Rep. John James, former Michigan Attorney General Mike Cox, state Senate Leader Aaric Nesbitt and former Michigan House speaker Tom Leonard are jockeying for the nomination.

In his bid to become secretary of state, Gilchrist will face four other Democrats: Barb Byrum, Ingham County clerk; Aghogho Edevbie, deputy secretary of state; Suzanna Shkreli, a former Whitmer aide and commissioner of the Michigan State Lottery; and Adam Hollier, a former state senator from Detroit.

Michigan does not hold primary elections for the secretary of state position; the nominee is chosen by precinct delegates during party conventions. The Michigan Democratic Party convention is scheduled for April 19.

State Republicans plan to hold their nominating convention March 28 and GOP figures chasing the party's nomination for secretary of state include Anthony Forlini, Macomb County Clerk, and Monica Yatooma, an Oakland County executive.

In addition to the office of the governor and secretary of state, Michigan voters will be selecting a new state attorney general and a U.S. senator in November.

FILE - Michigan Lt. Gov. Garlin Gilchrist II waits before the State of the State address, Wednesday, Jan. 24, 2024, at the state Capitol in Lansing, Mich. (AP Photo/Al Goldis, file)